Sign in

CIK 0001801170 · Large accelerated filer

CLOVER HEALTH INVESTMENTS, CORP. /DE

Sign in to watch
Ticker
CLOV
Exchange
Nasdaq
Industry
Hospital & Medical Service Plans
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
981515192
Phone
(201) 432-2133
Business address
30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
Former names
Social Capital Hedosophia Holdings Corp. III
  1. 4 Planned sale CEO, Medicare Advantage sold 9,273 shares at $4.78 ($44,325)
  2. 4 Open-market sale VP OF FINANCE AND CONTROLLER sold 20,000 shares at $5.16 ($103,200)
  3. 4 Planned sale Interim CFO sold 17,775 shares at $4.39 ($78,032)
  4. 4 Grant or award Chief Legal Officer acquired 108,695 shares (grant or award)
  5. 4 Grant or award Interim CFO acquired 54,347 shares (grant or award)
  6. 4 Planned sale Chief Executive Officer sold 87,798 shares at $4.65 ($408,261)
  7. 4 Planned sale Chief Legal Officer sold 51,700 shares at $4.51 ($233,167)
  8. 4 Planned sale CEO, Medicare Advantage sold 4,839 shares at $4.53 ($21,921)
  9. 4 Planned sale Chief Executive Officer sold 62,711 shares at $4.67 ($292,860)
  10. 4 Planned sale CEO, Counterpart Health sold 24,215 shares at $4.67 ($113,084)
  11. 4 Planned sale CEO, Medicare Advantage sold 13,119 shares at $4.67 ($61,266)
  12. 4 Planned sale Chief Legal Officer sold 10,519 shares at $4.67 ($49,124)
  13. 4 Planned sale Interim CFO sold 4,630 shares at $4.67 ($21,622)
  14. 4 Planned sale CEO, Medicare Advantage sold 2,384 shares at $4.68 ($11,157)
  15. 4 Planned sale CEO, Medicare Advantage sold 6,229 shares at $5.26 ($32,765)
  16. 4 Planned sale Chief Executive Officer sold 313,476 shares at $5.32 ($1,667,692)
  17. 4 Planned sale CEO, Medicare Advantage sold 2,360 shares at $4.78 ($11,281)
  18. 4 Planned sale VP OF FINANCE AND CONTROLLER sold 12,102 shares at $4.86 ($58,816)
  19. 4 Planned sale Chief Legal Officer sold 4,681 shares at $4.61 ($21,579)
  20. 4 Planned sale CEO, Medicare Advantage sold 6,350 shares at $4.61 ($29,274)

Page 2 of 18 · 351 filings